← FDA Drug Approvals (Drugs@FDA)

EMEND

NDA · New Drug Application · Sponsor: MSD MERCK CO · Approved 2015-12-17

Drug application

FDA Application #

NDA207865

Application type

New Drug Application

Brand name

EMEND

Generic name

APREPITANT

Active ingredients

APREPITANT

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

MSD MERCK CO

Manufacturer

Merck Sharp & Dohme LLC

First approval

2015-12-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown